We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
38 hedge funds and large institutions have $58.1M invested in Corvus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
151% more call options, than puts
Call options by funds: $361K | Put options by funds: $144K
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
0% more funds holding
Funds holding: 38 → 38 (0)
3.27% less ownership
Funds ownership: 61.4% → 58.13% (-3.3%)
14% less capital invested
Capital invested by funds: $67.5M → $58.1M (-$9.44M)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
7
Reduced
13
Closed
6
Calls
$361K
Puts
$144K
Net Calls
+$217K
Net Calls Change
+$26K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$805K |
| 2 |
TI
Telemetry Investments
New York
|
+$761K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$84.6K |
| 5 |
Capstone Investment Advisors
New York
|
+$71.6K |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.18M |
| 2 |
Millennium Management
New York
|
-$1.05M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$588K |
| 4 |
CA
CHI Advisors
New York
|
-$372K |
| 5 |
BlackRock
New York
|
-$369K |
